Literature DB >> 8698521

Repertoire of transcribed peripheral blood T-cell receptor beta chain variable-region genes in acute rheumatic fever.

W G Abbott1, M A Skinner, L Voss, D Lennon, P L Tan, J D Fraser, I J Simpson, R Ameratunga, A Geursen.   

Abstract

Patients with severe group A streptococcal infections have abnormalities in the Vbeta repertoire of peripheral blood T cells that are consistent with superantigen stimulation by cytoplasmic membrane proteins. The purpose of this study was to determine whether similar changes in Vbeta repertoire could be found for patients with acute rheumatic fever (ARF). The mean Vbeta repertoire of peripheral blood T cells in nine hospitalized ARF patients was similar to that of 34 controls and did not change during 6 months of follow-up in 6 of the ARF subjects. We were unable to detect changes in the Vbeta repertoire of peripheral blood T cells from patients with ARF that could be attributed to the influence of a superantigen.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698521      PMCID: PMC174152          DOI: 10.1128/iai.64.7.2842-2845.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Cellular and biochemical responses of human T lymphocytes stimulated with streptococcal M proteins.

Authors:  M Kotb; H S Courtney; J B Dale; E H Beachey
Journal:  J Immunol       Date:  1989-02-01       Impact factor: 5.422

2.  T cell antigen receptor V gene usage. Increases in V beta 8+ T cells in Crohn's disease.

Authors:  D N Posnett; I Schmelkin; D A Burton; A August; H McGrath; L F Mayer
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

Review 3.  The immunology of rheumatic fever.

Authors:  L M Cairns
Journal:  N Z Med J       Date:  1988-06-08

4.  Studies of peripheral blood T lymphocytes in assessment of disease activity in rheumatic fever.

Authors:  M Hafez; F el-Shannawy; S el-Salab; Z el-Morsi; M el-Ziny; Y Al-Tonbary; A Abdalla; A Abou-el-Enein
Journal:  Br J Rheumatol       Date:  1988-06

5.  Blastogenic responses of human lymphocytes to structurally defined polypeptide fragments of streptococcal M protein.

Authors:  J B Dale; W A Simpson; I Ofek; E H Beachey
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

6.  Separation of T-cell-stimulating activity from streptococcal M protein.

Authors:  B Fleischer; K H Schmidt; D Gerlach; W Köhler
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

7.  The influence of a maternal chronic hepatitis B virus infection on the repertoire of transcribed T-cell receptor beta chain variable region genes in human cord blood.

Authors:  W G Abbott; A Geursen; J D Fraser; J Marbrook; M A Skinner; P L Tan
Journal:  Hepatology       Date:  1995-10       Impact factor: 17.425

8.  Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease.

Authors:  J Abe; B L Kotzin; K Jujo; M E Melish; M P Glode; T Kohsaka; D Y Leung
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

9.  Superantigenicity of streptococcal M protein.

Authors:  M Tomai; M Kotb; G Majumdar; E H Beachey
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

10.  Selective expansion of T cells expressing V beta 2 in toxic shock syndrome.

Authors:  Y Choi; J A Lafferty; J R Clements; J K Todd; E W Gelfand; J Kappler; P Marrack; B L Kotzin
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

View more
  1 in total

1.  Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks.

Authors:  Laura M Smoot; John K McCormick; James C Smoot; Nancy P Hoe; Ian Strickland; Robert L Cole; Kent D Barbian; Cathleen A Earhart; Douglas H Ohlendorf; L George Veasy; Harry R Hill; Donald Y M Leung; Patrick M Schlievert; James M Musser
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.